30 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
of Directors in Uncontested Elections
Plurality
Diversity of Board Background, Experience and Skills
Yes
RECENT CORPORATE HIGHLIGHTS
In May 2023, we … of the Company and its stockholders;
Ability to contribute to the diversity of personal and professional experiences, skills, knowledge, opinions, perspectives
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
processes utilizing good manufacturing practices for biologics and small molecules. We believe that our management team’s diverse mix of skills provides
424B5
LRMR
Larimar Therapeutics Inc
13 Feb 24
Prospectus supplement for primary offering
4:46pm
of manufacturing processes utilizing good manufacturing practices for biologics and small molecules. We believe that our management team’s diverse mix of skills
424B5
knbpo4lidk7h8vgj
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-10.1
47tf8q0vm34
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.2
nlimpotbedd9kht
26 Jun 20
Other Events
5:08pm
8-K
EX-10.4
esj74svvk7juic196r
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
7xi9edg773q1beuf
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
21hij4k31sba
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
g43k6vjjbj 16
6 Mar 20
Preliminary proxy related to merger
5:32pm